Stock Analysis of Hillevax Inc (HLVX) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code HLVX
Close 12.14
Change 0.0100 / 0.082 %
Volume 180858
Vol Change 22844.00 / 14.46 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBearish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Low Stability Stock


Fundamental View of Hillevax Inc


Highs/Lows of Hillevax Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week12.89 5.82 % 0.513 % 13.94510.93528-May-2428-May-24
Two Week15.84 23.36 % 0.486 % 15.8210.93520-May-2428-May-24
One Month13.2 8.03 % 4.80 % 16.30510.93516-May-2428-May-24
Three Month18.15 33.11 % 3.56 % 20.2210.93504-Mar-2428-May-24
Six Months13.71 11.45 % 15.54 % 20.2210.93504-Mar-2428-May-24
One year17.02 28.67 % 26.26 % 20.229.9404-Mar-2423-Oct-23
Two year9.88 22.87 % 27.72 % 23.19.9401-Nov-2223-Oct-23


Technical View of Hillevax Inc






Charts of Hillevax Inc


Returns of Hillevax Inc with Peers
Period / StockHLVXITOSINNVSRDX
1 Week-5.82%-5.32%-1.33%22.34%
1 Mth-8.03%55.87%25.07%63.72%
3 Mth-33.11%56.30%-8.26%31.85%
6mth-11.45%78.85%-24.36%28.15%
1 Year-28.67%2.83%-34.03%129.46%
2 Year22.87%-4.34%-8.45%7.21%
5 Years---3.70%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Hillevax Inc with Peers
Ratio / StockHLVXITOSINNVSRDX
PE-828.48-4.43-19.5714.81
P/B469.971.001.955.11
ROA-44.48-19.86-5.6222.19
ROE-56.73-22.62-10.3834.52
Debt To Equity0.1070.00220.04070.252
Revenue0
%
66500.00 K
24747.74 %
688087 K
1.51 %
132584 K
32.65 %
Net Income-107794.00 K
32.55 %
-61638.00 K
63873.12 %
-40673.00 K
523.72 %
6510.00 K
123.87 %


Technicals of Hillevax Inc with Peers
Technical / StockHLVXITOSINNVSRDX-
ADX18.7149.0114.5547.95
CMF-0.0319-0.133-0.172-0.419
MFI36.4050.9648.2162.99
RSI37.0160.9955.6381.70
MACD Abv SignalFalseFalseTrueTrue
Price Above 50 MAFalseTrueTrueTrue-
Price Above 200 MAFalseTrueFalseTrue-


About : Hillevax Inc


Address : 75 State Street, Boston, MA, United States, 02109
Tel : 617 213 5054
URL : https://www.hillevax.com
Code : HLVX, ISIN : US43157M1027, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 29_Apr_2022
Employee Count : 90

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.


Note : All Data Generated at the End of Trading Hours (EOD Data)